DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jhzf53/huntingtons) has announced the addition of the "Huntington's Disease - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Huntington's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Huntington's Disease and special features on late-stage and discontinued projects.
This report features investigational drugs from across the globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles/records featured in the report undergo periodic updates following a stringent set of processes that ensure that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Companies Mentioned
-
Acadia Pharmaceuticals
-
Addex Therapeutics
-
BioCrea
- BioMarin Pharmaceutical
- Cortex Pharmaceuticals
- CrystalGenomics
- EncephRx
-
Evotec
-
F. Hoffmann-La Roche
-
Galenea
- Genervon Biopharmaceuticals
-
Ipsen
- Isis Pharmaceuticals
- Kadmon Corporation
- KineMed
-
Living Cell Technologies
- Marathon Pharmaceuticals
-
Medesis Pharma
- Neuralstem
- Neurimmune
- Omeros
-
Oryzon Genomics
- Pfizer
- PharmatrophiX
- Raptor Pharmaceuticals
- reMYND
- Sangamo BioSciences
-
Siena Biotech
-
Teva Pharmaceutical Industries
-
Treventis
-
Ultragenyx Pharmaceutical
-
uniQure
- Vaccinex
- Varine
- Zenobia Therapeutics
For more information visit http://www.researchandmarkets.com/research/jhzf53/huntingtons
